AAAAAA
Results: 26-50/72
Authors:
Kamphuisen, PW
Rosendaal, FR
Eikenboom, JCJ
Bos, R
Bertina, RM
Citation: Pw. Kamphuisen et al., Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels, ART THROM V, 20(5), 2000, pp. 1382-1386
Authors:
Vandenbroucke, JP
Helmerhorst, FM
Rosendaal, FR
Citation: Jp. Vandenbroucke et al., Competing interests and controversy about third generation oral contraceptives - BMJ readers should know whose words they read, BR MED J, 320(7231), 2000, pp. 381-382
Authors:
Vandenbroucke, JP
Bloemenkamp, KWM
Rosendaal, FR
Helmerhorst, FM
Citation: Jp. Vandenbroucke et al., Incidence of venous thromboembolism in users of combined oral contraceptives - Risk is particularly high with first use of oral contraceptives, BR MED J, 320(7226), 2000, pp. 57-57
Authors:
Doggen, CJM
Berckmans, RJ
Sturk, A
Cats, VM
Rosendaal, FR
Citation: Cjm. Doggen et al., C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men, J INTERN M, 248(5), 2000, pp. 406-414
Authors:
Psaty, BM
Doggen, C
Vos, HL
Vandenbroucke, JP
Rosendaal, FR
Citation: Bm. Psaty et al., Association of the alpha-adducin polymorphism with blood pressure and riskof myocardial infarction, J HUM HYPER, 14(2), 2000, pp. 95-97
Authors:
Weijl, NI
Rutten, MFJ
Zwinderman, AH
Keizer, HJ
Nooy, MA
Rosendaal, FR
Cleton, FJ
Osanto, S
Citation: Ni. Weijl et al., Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature, J CL ONCOL, 18(10), 2000, pp. 2169-2178
Authors:
Doggen, CJM
de Visser, MCH
Vos, HL
Bertina, RM
Cats, VM
Rosendaal, FR
Citation: Cjm. Doggen et al., The HR2 haplotype of factor V is not associated with the risk of myocardial infarction, THROMB HAEM, 84(5), 2000, pp. 815-818
Authors:
Lensen, RPM
Bertina, RM
de Ronde, H
Vandenbroucke, JP
Rosendaal, FR
Citation: Rpm. Lensen et al., Venous thrombotic risk in family members of unselected individuals with factor V Leiden, THROMB HAEM, 83(6), 2000, pp. 817-821
Authors:
de Visser, MCH
Guasch, JF
Kamphuisen, PW
Vos, HL
Rosendaal, FR
Bertina, RM
Citation: Mch. De Visser et al., The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis, THROMB HAEM, 83(4), 2000, pp. 577-582
Authors:
Eekhoff, EMW
Rosendaal, FR
Vandenbroucke, JP
Citation: Emw. Eekhoff et al., Minor events and the risk of deep venous thrombosis, THROMB HAEM, 83(3), 2000, pp. 408-411
Authors:
Rosendaal, FR
Citation: Fr. Rosendaal, High levels of factor VIII and venous thrombosis, THROMB HAEM, 83(1), 2000, pp. 1-2
Authors:
Van Driel, D
Wesseling, J
Rosendaal, FR
Odink, RJ
Van der Veer, E
Gerver, WJ
Geven-Boere, LM
Sauer, PJJ
Citation: D. Van Driel et al., Growth until puberty after in utero exposure to coumarins, AM J MED G, 95(5), 2000, pp. 438-443
Authors:
Thomassen, R
Vandenbroucke, JP
Rosendaal, FR
Citation: R. Thomassen et al., Antipsychotic drugs and venous thromboembolism, LANCET, 356(9225), 2000, pp. 252-252
Authors:
Reiner, AP
Kumar, PN
Schwartz, SM
Longstreth, WT
Pearce, RM
Rosendaal, FR
Psaty, BM
Siscovick, DS
Citation: Ap. Reiner et al., Genetic variants of platelet glycoprotein receptors and risk of stroke in young women, STROKE, 31(7), 2000, pp. 1628-1633
Authors:
Meijers, JCM
Rosendaal, FR
Citation: Jcm. Meijers et Fr. Rosendaal, Coagulation factor XI and venous thrombosis - Reply, N ENG J MED, 343(3), 2000, pp. 221-221
Authors:
Meijers, JCM
Tekelenburg, WLH
Bouma, BN
Bertina, RM
Rosendaal, FR
Citation: Jcm. Meijers et al., High levels of coagulation factor XI as a risk factor for venous thrombosis., N ENG J MED, 342(10), 2000, pp. 696-701
Authors:
Sramek, A
Bosch, JG
Reiber, JHC
Van Oostayen, JA
Rosendaal, FR
Citation: A. Sramek et al., Ultrasound assessment of atherosclerotic vessel wall changes - Reproducibility of intima-media thickness measurements in carotid and femoral arteries, INV RADIOL, 35(12), 2000, pp. 699-706
Authors:
Doggen, CJM
Bertina, RM
Cats, VM
Rosendaal, FR
Citation: Cjm. Doggen et al., Fibrinogen polymorphisms are not associated with the risk of myocardial infarction, BR J HAEM, 110(4), 2000, pp. 935-938
Authors:
Kamphuisen, PW
Lensen, R
Houwing-Duistermaat, JJ
Eikenboom, JCJ
Harvey, M
Bertina, RM
Rosendaal, FR
Citation: Pw. Kamphuisen et al., Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia, BR J HAEM, 109(3), 2000, pp. 519-522
Authors:
Blann, AD
Noteboom, WMP
Rosendaal, FR
Citation: Ad. Blann et al., Increased soluble P-selectin levels following deep venous thrombosis: cause or effect, BR J HAEM, 108(1), 2000, pp. 191-193
Authors:
Janssen, HLA
Meinardi, JR
Vleggaar, FP
van Uum, SHM
Haagsma, EB
van der Meer, FJM
van Hattum, J
Chamuleau, RAFM
Adang, RP
Vandenbroucke, JP
van Hoek, B
Rosendaal, FR
Citation: Hla. Janssen et al., Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study, BLOOD, 96(7), 2000, pp. 2364-2368
Authors:
van Tilburg, NH
Rosendaal, FR
Bertina, RM
Citation: Nh. Van Tilburg et al., Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis, BLOOD, 95(9), 2000, pp. 2855-2859
Authors:
Vlieg, AV
van der Linden, IK
Bertina, RM
Rosendaal, FR
Citation: Av. Vlieg et al., High levels of factor IX increase the risk of venous thrombosis, BLOOD, 95(12), 2000, pp. 3678-3682
Authors:
Zidane, M
Schram, MT
Planken, EW
Molendijk, WH
Rosendaal, FR
van der Meer, FJM
Huisman, MV
Citation: M. Zidane et al., Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice, ARCH IN MED, 160(15), 2000, pp. 2369-2373
Authors:
Kaplan, RC
Heckbert, SR
Koepsell, TD
Rosendaal, FR
Psaty, BM
Citation: Rc. Kaplan et al., Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding, ARCH IN MED, 160(12), 2000, pp. 1849-1855